.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chubb
Dow
Cipla
QuintilesIMS
Teva
McKesson
McKinsey
US Department of Justice
Queensland Health

Generated: November 18, 2017

DrugPatentWatch Database Preview

QUELICIN Drug Profile

« Back to Dashboard

Which patents cover Quelicin, and when can generic versions of Quelicin launch?

Quelicin is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in QUELICIN is succinylcholine chloride. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.

Pharmacology for QUELICIN

Medical Subject Heading (MeSH) Categories for QUELICIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
QUELICIN
succinylcholine chloride
INJECTABLE;INJECTION008845-006Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira
QUELICIN PRESERVATIVE FREE
succinylcholine chloride
INJECTABLE;INJECTION008845-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
QUELICIN PRESERVATIVE FREE
succinylcholine chloride
INJECTABLE;INJECTION008845-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira
QUELICIN PRESERVATIVE FREE
succinylcholine chloride
INJECTABLE;INJECTION008845-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Argus Health
Covington
Cipla
US Department of Justice
UBS
Mallinckrodt
Chubb
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot